Lasmiditan Succinate Tablet shortage
To Be Discontinued 6 presentations · 1 manufacturers · first FDA posting 2025-11-03 · last update 2025-11-03
Manufacturers: Eli Lilly and Co.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Reyvow, Tablet, 50 mg (NDC 0002-4312-08) | Eli Lilly and Co. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026. | Posted 11/03/2025 Updated 11/03/2025 Discontinued 11/03/2025 |
| Reyvow, Tablet, 50 mg (NDC 0002-4312-61) | Eli Lilly and Co. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026. | Posted 11/03/2025 Updated 11/03/2025 Discontinued 11/03/2025 |
| Reyvow, Tablet, 50 mg (NDC 0002-4312-62) | Eli Lilly and Co. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026. | Posted 11/03/2025 Updated 11/03/2025 Discontinued 11/03/2025 |
| Reyvow, Tablet, 100 mg (NDC 0002-4491-08) | Eli Lilly and Co. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026. | Posted 11/03/2025 Updated 11/03/2025 Discontinued 11/03/2025 |
| Reyvow, Tablet, 100 mg (NDC 0002-4491-61) | Eli Lilly and Co. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026. | Posted 11/03/2025 Updated 11/03/2025 Discontinued 11/03/2025 |
| Reyvow, Tablet, 100 mg (NDC 0002-4491-62) | Eli Lilly and Co. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026. | Posted 11/03/2025 Updated 11/03/2025 Discontinued 11/03/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)